CNA Transitions to AIR Worldwide as its Primary Catastrophe Risk Management Platform

Boston, July 13, 2020 (GLOBE NEWSWIRE) — Catastrophe modeling firm AIR Worldwide announced that CNA has transitioned to AIR’s Touchstone solution as its primary catastrophe risk modeling platform. AIR Worldwide is a Verisk (Nasdaq:VRSK) business. “We are excited to leverage AIR’s powerful catastrophe modeling solution to support our multiple lines of business during the underwriting […]

Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 for the Treatment of Angelman Syndrome in Europe

Angelini Pharma obtains exclusive development, manufacturing and commercialization rights to OV101 (gaboxadol) for the potential treatment of Angelman syndrome in the European Union and other countries in the European Economic Area (Switzerland, Turkey and the United Kingdom) and Russia Ovid Therapeutics will receive an upfront payment of $20 million and additional payments of up to […]

Trip.com Group releases “2020 Dragon Boat Festival Holiday Big Data Report”

Diagram of Hot Airlines During Dragon Boat Festival SINGAPORE, July 13, 2020 (GLOBE NEWSWIRE) — Leading international online travel services provider Trip.com Group has highlighted the latest positive trends in travel in its recently released “2020 Dragon Boat Festival Holiday Tourism Big Data Report” for the China market. With view to the China travel market, […]

Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016 in China

SHANGHAI, China, July 12, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today the completion of study subjects enrollment in Phase I trial of SARS-CoV-2 neutralizing monoclonal antibody injection (Product Code: JS016), developed jointly with Institute of Microbiology, Chinese […]

Junshi Biosciences Announces Approval of “B” Marker Removal from Company’s Stock Name by HKEX

SHANGHAI, China, July 12, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that following its application to The Stock Exchange of Hong Kong Limited (HKEX) pursuant to Rule 18A.12 of the Rules Governing the Listing of Securities on […]

Singapore’s ruling party holds on to power but faces setback

Singapore Prime Minister Lee Hsien Loong’s long-governing party comfortably won Friday’s general elections as expected amid the coronavirus pandemic, but faced a setback as the opposition made minor gains. Lee said his People’s Action Party secured 83 parliamentary seats, retaining its

Top